nominally significantp -value ≤ 0.05
We identified nominally significant ( p -value ≤ 0.05) alteration after doxorubicin treatment in 127 metabolites measured on the HD4 platform.
We identified nominally significant ( p -value ≤ 0.05) alteration after doxorubicin treatment in 127 metabolites measured on the HD4 platform.